Related Experiment Video
Updated: Feb 23, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Controversies and advances in the management of ventilator associated pneumonia
Katherine L Roberts1, Scott T Micek2, Paul Juang2
1a Department of Pharmacy , Barnes Jewish Hospital , St Louis , MO , USA.
Introduction:
Although national surveillance data suggests that the incidence of ventilator associated pneumonia (VAP) is down-trending, it remains one of the most commonly encountered hospital acquired infections in the United States and worldwide. Its association with increased healthcare costs and worsened patient outcomes warrants continued effort to improve the care of patients with VAP. Areas covered: The increasing prevalence of multi-drug resistant bacteria further drives the need to explore advances in diagnostic and treatment options. In this review, controversies pertaining to the definition and diagnosis of VAP as well as empiric treatment strategies will be discussed along with several developments related to rapid microbiologic testing methods and the use of non-traditional antimicrobial agents. Expert commentary: The application of rapid diagnostic techniques to identify microbial pathogens is perhaps one of the most impactful advancements in the treatment of serious nosocomial infections. This technology has the potential to reduce inappropriate initial antimicrobial therapy, unnecessary antimicrobial exposure, and mortality in patients with VAP. In addition, the anticipated approval of new antimicrobial agents within the next several years will provide a much-needed expansion of available treatment options in an era of growing antimicrobial resistance.
Insights
Ventilator-associated pneumonia (VAP) remains a significant hospital-acquired infection. Advances in rapid diagnostics and new antimicrobial agents offer improved treatment options for VAP, especially with rising drug resistance.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Antimicrobial Resistance
Background:
- Ventilator-associated pneumonia (VAP) is a common hospital-acquired infection with significant healthcare costs and negative patient outcomes.
- The rising prevalence of multi-drug resistant bacteria complicates VAP management, necessitating advancements in diagnostics and therapeutics.
- Despite a downward trend in national surveillance data, VAP remains a critical concern globally.
Purpose of the Study:
- To review current controversies in the definition and diagnosis of VAP.
- To discuss evolving empiric treatment strategies for VAP.
- To highlight recent developments in rapid microbiologic testing and novel antimicrobial agents for VAP.
Main Methods:
- Literature review focusing on VAP definition, diagnosis, and treatment strategies.
- Discussion of advancements in rapid diagnostic techniques for microbial pathogen identification.
- Exploration of emerging non-traditional antimicrobial agents and their potential role in VAP management.
Main Results:
- Rapid diagnostic techniques show potential to reduce inappropriate antimicrobial therapy, decrease unnecessary exposure, and lower mortality in VAP patients.
- New antimicrobial agents are anticipated, offering expanded treatment options against resistant pathogens.
- Controversies in VAP definition and diagnosis persist, requiring careful consideration in clinical practice.
Conclusions:
- Rapid diagnostic technologies represent a significant advancement in treating nosocomial infections like VAP.
- The development of new antimicrobial agents is crucial for combating antimicrobial resistance in VAP.
- Continued efforts are needed to refine VAP care, diagnostics, and treatment in light of evolving challenges.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation I: Indication and Settings
Pneumonia III: Complications and Assessment

